Introduction of Gardasil®9 vaccine from 2018
Gardasil®9 (9-valent human papillomavirus - 9vHPV) vaccine, will be listed on the National Immunisation Program from 1 January 2018.
Adolescent girls and boys in Year 7 of secondary school or aged 12-13 years will be offered Gardasil®9. It is a 2-dose schedule with a minimum 6 months between the doses.
Immunocompromised people and those aged 15 years and over require 3 doses of Gardasil®9.
Gardasil®9 includes the vaccine types covered by Gardasil® (6, 11 ,16, 18) plus an additional 5 oncogenic HPV types (31, 33, 45, 52 and 58).